Return to search results.
Complete title: A Phase III Clinical Trial of Intra-arterial TheraSphere in the Treatment of Patient with Unresectable Hepatocellular Carcinoma (HCC)
|Research Study Number||20111617|
|Principal Investigator||William Harris|
Research Study Description
Eligibility Criteria (must meet the following to participate in this study)
Genders Eligible for Study: Both
- Unresectable advanced HCC not amenable to curative procedures, with planned standard-of-care sorafenib therapy
Other eligibility criteria may apply.
Exclusions (conditions that would prevent participation in this study)
Other exclusion criteria may apply.
Gastrointestinal Cancer; Liver Cancer; Solid Tumors
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.